• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Harrow, Inc. - Common Stock (NQ:HROW)

34.10 -1.46 (-4.11%)
Streaming Delayed Price Updated: 4:00 PM EDT, Mar 13, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,182,438
Open 35.80
Bid (Size) 34.10 (200)
Ask (Size) 34.46 (300)
Prev. Close 35.56
Today's Range 33.74 - 36.15
52wk Range 20.85 - 54.85
Shares Outstanding 37,229,705
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Investment Manager Fully Exits Immunome Stock in $37.3 Million Sale, According to Latest SEC Filing ↗
March 04, 2026
Immunome develops antibody therapeutics for cancer and infectious diseases, reporting a market cap above $2 billion in the latest filing. 
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Investment Manager Sells $5.1 Million Worth of LQDA Stock, According to Recent SEC Filing ↗
March 04, 2026
Liquidia develops inhaled and injectable therapies for pulmonary arterial hypertension, targeting unmet needs in the U.S. biopharma market. 
Via The Motley Fool
Topics Regulatory Compliance

Performance

YTD
-31.7%
-31.7%
1 Month
-27.6%
-27.6%
3 Month
-25.4%
-25.4%
6 Month
-20.4%
-20.4%
1 Year
+48.2%
+48.2%

More News

Read More
What's going on in today's session ↗
March 03, 2026
Via Chartmill
Harrow Inc (NASDAQ:HROW) Stock Plummets 13% After Q4 Earnings Miss ↗
March 02, 2026
Via Chartmill
HARROW INC (NASDAQ:HROW) Emerges as a High-Growth Momentum Stock with Strong Technical Setup ↗
January 03, 2026
Via Chartmill
News headline image
Earnings Scheduled For November 10, 2025 ↗
November 10, 2025
Via Benzinga
Harrow To Acquire Sedation Solutions Developer Melt Pharmaceuticals – More Details Inside ↗
September 26, 2025
Via Stocktwits
News headline image
Demystifying Harrow: Insights From 5 Analyst Reviews ↗
September 23, 2025
Via Benzinga
These stocks are moving in today's session ↗
March 03, 2026
Via Chartmill
News headline image
Harrow (HROW) Q4 2025 Earnings Call Transcript ↗
March 03, 2026
Via The Motley Fool
Topics Earnings
Which stocks are gapping on Tuesday? ↗
March 03, 2026
Via Chartmill
These stocks are moving in today's after hours session ↗
March 02, 2026
Via Chartmill
News headline image
A Preview Of Harrow's Earnings ↗
August 08, 2025
Via Benzinga
News headline image
Private Equity-Style Fund Buys $15.7 Million in Harrow Stock as Revenue Jumps 45% ↗
November 27, 2025
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Outset Medical, Gemini Space Station, CoreWeave And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session ↗
November 11, 2025
Via Benzinga
News headline image
These stocks are moving in today's after hours session ↗
November 10, 2025
Via Chartmill
News headline image
Could Harrow's New Sedation Pill Change Millions Of Medical Procedures Forever? ↗
September 26, 2025
Via Benzinga
News headline image
Tesla To Rally Around 4%? Here Are 10 Top Analyst Forecasts For Tuesday ↗
September 23, 2025
Via Benzinga
News headline image
HARROW INC (NASDAQ:HROW) Presents High Growth Momentum and Technical Breakout Opportunity ↗
August 29, 2025
Via Chartmill
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Harrow, Inc. – HROW
August 17, 2025
From Pomerantz LLP
Via GlobeNewswire
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Harrow, Inc. – HROW
August 13, 2025
From Pomerantz LLP
Via GlobeNewswire
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Harrow, Inc. – HROW
August 09, 2025
From Pomerantz LLP
Via GlobeNewswire
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Harrow, Inc. – HROW
August 05, 2025
From Pomerantz LLP
Via GlobeNewswire
News headline image
Earnings Scheduled For August 11, 2025 ↗
August 11, 2025
Via Benzinga
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Harrow, Inc. – HROW
August 01, 2025
From Pomerantz LLP
Via GlobeNewswire

Frequently Asked Questions

Is Harrow, Inc. - Common Stock publicly traded?
Yes, Harrow, Inc. - Common Stock is publicly traded.
What exchange does Harrow, Inc. - Common Stock trade on?
Harrow, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Harrow, Inc. - Common Stock?
The ticker symbol for Harrow, Inc. - Common Stock is HROW on the Nasdaq Stock Market
What is the current price of Harrow, Inc. - Common Stock?
The current price of Harrow, Inc. - Common Stock is 34.10
When was Harrow, Inc. - Common Stock last traded?
The last trade of Harrow, Inc. - Common Stock was at 03/13/26 04:00 PM ET
What is the market capitalization of Harrow, Inc. - Common Stock?
The market capitalization of Harrow, Inc. - Common Stock is 1.27B
How many shares of Harrow, Inc. - Common Stock are outstanding?
Harrow, Inc. - Common Stock has 1B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap